We are monitoring the impact of COVID-19 on North America Erythropoietin Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6537
Share on
Share on

North America Erythropoietin Drugs Market Research Report - Segmented By Product, By Application, By Drug Class & By Country (U.S, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2020-2025)

Pulished: February, 2020
ID: 6537
Pages: 145

North America Erythropoietin Drugs Market Size & Growth (2020 - 2025)

As per the research report, the size of the North America Erythropoietin Drugs Market was valued at USD 2.87 billion in 2020 and estimated to be growing at a CAGR of 9.6%, to reach USD 4.61 billion by 2025 during the forecast period 2020-2025.

Erythropoietin is present in the bone marrow cells controlling the production of red blood cells. They can be used for the treatment of anaemia, HIV and Cancer. Various synthetic forms of erythropoietin are available in the market due to advancements in recombinant DNA technology.

Increased incidence of anaemia, rising commercialisation of EPO drugs and favourable reimbursement policies are further driving the market growth. As cheaper biosimilars are also available the market is expected to propel during the forecast period.

This research report segmented and sub-segmented into the following categories:

  • By Product: Epoetin-alpha, Epoetin-beta, Darbepoetin-alfa and Others
  • By Application: Cancer, Haematology, Renal Diseases and Neurology
  • By Drug Class: Biologics and Biosimilar
  • By Country: U.S, Canada and Rest of North America

North America held a considerable share in the Erythropoietin Drugs market.

Companies playing a dominant role in the North America Erythropoietin Drugs Market profiled in this report are Johnson & Johnson, Celltrion, Inc, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr Reddy’s Laboratories Ltd.Amgen, Inc., F. Hoffmann-La Roche Ltd., LG Life Sciences Ltd., Biocon Limited and Intas Pharmaceuticals Ltd.


                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product                                                        

                                5.1.1 Introduction                                           

                                5.1.2 Epoetin-alfa                                            

                                5.1.3 Epoetin-beta                                          

                                5.1.4 Darbepoetin-alfa                                  

                                5.1.5  Y-o-Y Growth Analysis, By Product                                              

                                5.1.6  Market Attractiveness Analysis, By Product                                            

                                5.1.7  Market Share Analysis, By Product                                              

                5.2 Application                                                 

                                5.2.1 Introduction                                           

                                5.2.2 Cancer                                      

                                5.2.3 Hematology                                            

                                5.2.4 Renal diseases                                       

                                5.2.5 Y-o-Y Growth Analysis, By application                                         

                                5.2.6 Market Attractiveness Analysis, By application                                       

                                5.2.7 Market Share Analysis, By application                                         

                5.3 Drug class                                                    

                                5.3.1 Introduction                                           

                                5.3.2 Biologics                                   

                                5.3.3 Biosimilars                                               

                                5.3.4 Y-o-Y Growth Analysis, By drug class                                            

                                5.3.5  Market Attractiveness Analysis, By drug class                                         

                                5.3.6  Market Share Analysis, By drug class                                          

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                       By Geographical Area                     

                                       By Product                           

                                       By application                     

                                       By drug class                       

                                6.1.4  Market Attractiveness Analysis                                     

                                       By Geographical Area                     

                                       By Product                           

                                       By application                     

                                       By drug class                       

                                6.1.5  Market Share Analysis                                      

                                       By Geographical Area                     

                                       By Product                           

                                       By application                     

                                       By drug class                       

                6.2 United States                                                            

                6.3 Canada                                                         

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1  Johnson & Johnson                                                

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Celltrion, Inc.                                                             

                8.3 Teva Pharmaceutical Industries Ltd.                                                

                8.4 Amgen, Inc.                                                

                8.5 F. Hoffmann-La Roche Ltd.                                                  

                8.6 LG Life Sciences Ltd.                                                               

                8.7 Biocon Limited                                                          

                8.8 Intas Pharmaceuticals Ltd.                                                   

                8.9 Sun Pharmaceutical Industries Ltd.                                                  

                8.10 Dr. Reddy’s Laboratories Ltd.                                                           

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         


                a) List of Tables                                                

                b) List of Figures                                   

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the regions that are still untapped
  • The segment-level analysis in terms of Product, by Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Erythropoeitin Drugs Market By Product, From 2020-2025 ( USD Billion )
  2. North America Epoetin-alfa Market By Region, From 2020-2025 ( USD Billion )
  3. North America Epoetin-beta Market By Region, From 2020-2025 ( USD Billion )
  4. North America Darbepoetin-alfa Market By Region, From 2020-2025 ( USD Billion )
  5. North America Erythropoeitin Drugs Market By Application, From 2020-2025 ( USD Billion )
  6. North America Cancer Market By Region, From 2020-2025 ( USD Billion )
  7. North America Hematology Market By Region, From 2020-2025 ( USD Billion )
  8. North America Renal diseases Market By Region, From 2020-2025 ( USD Billion )
  9. North America Neurology Market By Region, From 2020-2025 ( USD Billion )
  10. North America Erythropoeitin Drugs Market By Drug class, From 2020-2025 ( USD Billion )
  11. North America Biologics Market By Region, From 2020-2025 ( USD Billion )
  12. North America Biosimilars Market By Region, From 2020-2025 ( USD Billion )
  13. United States Erythropoeitin Drugs Market By Product, From 2020-2025 ( USD Billion )
  14. United States Erythropoeitin Drugs Market By Application, From 2020-2025 ( USD Billion )
  15. United States Erythropoeitin Drugs Market By Drug class, From 2020-2025 ( USD Billion )
  16. Canada Erythropoeitin Drugs Market By Product, From 2020-2025 ( USD Billion )
  17. Canada Erythropoeitin Drugs Market By Application, From 2020-2025 ( USD Billion )
  18. Canada Erythropoeitin Drugs Market By Drug class, From 2020-2025 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample